Charles Butts, MD
Trauma Surgery · Mobile, ALNPI 1710244835
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,200 of the $13,088 with a category attached, or 62.7%. AstraZeneca accounts for 66.7% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2023 at $5,422 and has fallen 89.6% since, to $563 in 2025.
Across 116 payments — averaging $112.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$9K
- Integra Lifesciences Corporation$750
- Johnson & Johnson$661
- Smith+Nephew$562
- Prytime Medical Devices, Inc.$549
- Zimmer Biomet$495
- plus $1K from 17 others
Across 39 payments — averaging $14,681 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$556K
- Avita Medical Americas, LLC$17K
What the payments were for
- Speaking & faculty fees$8,20063%
- Travel & lodging$951%
- Food & beverage$4,79337%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 14 | $8,731 |
| Integra Lifesciences Corporation | 14 | $750 |
| Johnson & Johnson(2 entities) | 26 | $661 |
| Smith+Nephew | 15 | $562 |
| Prytime Medical Devices, Inc. | 1 | $549 |
| Zimmer Biomet | 10 | $495 |
| Polynovo North America LLC | 5 | $302 |
| Avita Medical Americas, LLC | 3 | $189 |
| Baxter Healthcare | 7 | $184 |
| Kerecis Limited | 3 | $135 |
| Kls-martin L.p. | 1 | $123 |
| Aroa Biosurgery Incorporated | 2 | $97 |
| Merck | 4 | $72 |
| Polarityte, Inc. | 1 | $61 |
| Paratek Pharmaceuticals, Inc. | 2 | $35 |
| Atricure, Inc. | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| Misonix Inc | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Acera Surgical, Inc. | 1 | $18 |
| CSL Behring | 1 | $18 |
| Astellas Pharma US Inc | 1 | $15 |
| Teleflex LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANDEXXA$8,569
- INTEGRA$908
- ER-REBOA PLUS$549
- INTEGRA DERMAL REGENERATION TEMPLATE$303
- PRIMATRIX$303
- Novosorb BTM$257
- CYTAL$203
- PERMEADERM$153
- RECELL$153
- Cohealyx$153
- ACTICOAT 4" X 4"$125
- Oasis$125
- COLLAGENASE SANTYL$125
- Versajet$125
- ACTICOAT$103
- RIBFIX BLU ADVANTAGE$103
How this compares
$13,088 in reported general payments places this provider in the 85th percentile of 26 trauma surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other trauma surgery in Mobile
- Maryann MbakaMobile$11K
- Christopher KinnardMobile$7K
- Sidney BrevardMobile$4K
- Scott BlairMobile$972
- Nathan PoliteMobile$903
- William BarberMobile$246
- John VermillionMontgomery$87K
- John HolcombBirmingham$45K
- Jan JansenBirmingham$18K
- James HwangBirmingham$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.